Accueil   Diary - News   All news Poxel Appoints Kumi Sato to its Board of Directors

Poxel Appoints Kumi Sato to its Board of Directors

LYON, France--(BUSINESS WIRE)-- POXEL SA (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes, today announced the addition of Kumi Sato, President and CEO of COSMO Public Relations Corporation, to its Board of Directors.

 

Ms. Sato is a seasoned executive with over 30 years’ experience advising companies in business and communication strategy, with a particular focus on Japanese business strategies for healthcare companies. The appointment was approved by Poxel’s shareholders at the Annual Shareholder Meeting, which was held in Paris on Friday, June 30, 2017.

 

 

Read the press release

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree